State KS
Clinical Trials in Kansas
Recruiting clinical trials with at least one study location in Kansas. Data updated daily from ClinicalTrials.gov.
Top Conditions in Kansas
NCT04951622 Phase 3
Recruiting
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Condition
Myasthenia Gravis
Enrollment
199 pts
Location
United States, Australia, Belgium
Sponsor
Janssen Research & Development
NCT07225946 Phase 3
Recruiting
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metas...
Condition
Prostatic Neoplasms, Castration-Resistant
Enrollment
800 pts
Location
United States, Australia, Brazil
Sponsor
Janssen Research & Development
NCT06568237 Phase 2
Recruiting
A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Mul...
Condition
Multiple System Atrophy
Enrollment
350 pts
Location
United States, France, Germany
Sponsor
Teva Branded Pharmaceutical Pr
NCT07104383 Phase 3
Recruiting
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
Condition
Weight Loss
Enrollment
1,100 pts
Location
United States, Puerto Rico
Sponsor
Viking Therapeutics, Inc.
NCT03981575 N/A
Recruiting
Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)
Condition
Myotonic Dystrophy 1
Enrollment
700 pts
Location
United States, Canada, Germany
Sponsor
Virginia Commonwealth Universi
NCT05762107 Phase 2
Recruiting
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Condition
Type 1 Diabetes Mellitus With Hypoglycemia
Enrollment
186 pts
Location
United States, Canada
Sponsor
Zucara Therapeutics Inc.
NCT05826665 N/A
Recruiting
Observational Study to Examine the Procedural and Outcomes of AF Ablation Assist...
Condition
Persistent Atrial Fibrillation
Enrollment
200 pts
Location
United States
Sponsor
Kansas City Heart Rhythm Resea
NCT05855200 Phase 3
Recruiting
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage ...
Condition
Colonic Neoplasms
Enrollment
892 pts
Location
United States, Argentina, Australia
Sponsor
GlaxoSmithKline
NCT06683092 N/A
Recruiting
Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
Condition
Cystic Fibrosis
Enrollment
200 pts
Location
United States
Sponsor
Boston Children's Hospital
NCT06636786 Phase 2
Recruiting
Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With Subli...
Condition
Acute Stress Reaction
Enrollment
180 pts
Location
United States
Sponsor
University of North Carolina,
NCT07206056 Phase 1, Phase 2
Recruiting
An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tul...
Condition
Progressive Metastatic Castrate Resistant Prostate Cancer
Enrollment
188 pts
Location
United States, Australia, China
Sponsor
Novartis Pharmaceuticals
NCT02325674 N/A
Recruiting
MEASuRE: Metreleptin Effectiveness And Safety Registry
Condition
Generalised Lipodystrophy
Enrollment
100 pts
Location
United States, France, Germany
Sponsor
Amryt Pharma
NCT04553770 Phase 2
Recruiting
Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatmen...
Condition
Early-stage Breast Cancer
Enrollment
88 pts
Location
United States
Sponsor
Jonsson Comprehensive Cancer C
NCT01804686 Phase 3
Recruiting
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Condition
Chronic Lymphocytic Leukemia
Enrollment
700 pts
Location
United States, Argentina, Australia
Sponsor
Janssen Research & Development
NCT06034002 Phase 1
Recruiting
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination W...
Condition
Myeloproliferative Neoplasms
Enrollment
230 pts
Location
United States
Sponsor
Incyte Corporation
NCT07204288 N/A
Recruiting
Lumbar & Sacroiliac Fusion Study Involving Previously Implanted Devices
Condition
Fusion of Spine
Enrollment
500 pts
Location
United States
Sponsor
Spinal Simplicity LLC
NCT07089888 Phase 3
Recruiting
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Condition
Tophaceous Gout
Enrollment
250 pts
Location
United States
Sponsor
Crystalys Therapeutics
NCT05040360 Phase 2
Recruiting
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendo...
Condition
Metastatic Malignant Neoplasm in the Liver
Enrollment
141 pts
Location
United States, Mexico, Uruguay
Sponsor
SWOG Cancer Research Network
NCT07283939 N/A
Recruiting
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned...
Condition
Ampulla of Vater Carcinoma
Enrollment
420 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT06456242 N/A
Recruiting
Contingency Management to Promote Smoking Cessation
Condition
Smoking Cessation
Enrollment
20 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT03816345 Phase 1
Recruiting
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastati...
Condition
Autoimmune Disease
Enrollment
300 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
NCT06295367 N/A
Recruiting
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
Condition
Malignant Solid Neoplasm
Enrollment
760 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT06379724 Phase 4
Recruiting
Burn Study- Tranexamic Acid Versus Thrombin in Split Thickness Skin Graft
Condition
Burns
Enrollment
62 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT06866405 Phase 3
Recruiting
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vac...
Condition
RSV Infection
Enrollment
550 pts
Location
United States, Argentina, South Africa
Sponsor
Pfizer
NCT05491525 Phase 2, Phase 3
Recruiting
A Study of Vibegron in Pediatric Participants 2 Years to Less Than (<) 18 Years ...
Condition
Neurogenic Detrusor Overactivity
Enrollment
85 pts
Location
United States
Sponsor
Urovant Sciences GmbH